Annual Operating Profit
-$235.60 M
-$56.69 M-31.68%
December 31, 2023
Summary
- As of February 7, 2025, RNA annual operating income is -$235.60 million, with the most recent change of -$56.69 million (-31.68%) on December 31, 2023.
- During the last 3 years, RNA annual operating profit has fallen by -$191.32 million (-432.10%).
- RNA annual operating profit is now -2144.22% below its all-time high of -$10.50 million, reached on December 31, 2018.
Performance
RNA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$98.13 M
-$15.51 M-18.77%
September 1, 2024
Summary
- As of February 7, 2025, RNA quarterly operating income is -$98.13 million, with the most recent change of -$15.51 million (-18.77%) on September 1, 2024.
- Over the past year, RNA quarterly operating profit has dropped by -$39.51 million (-67.39%).
- RNA quarterly operating profit is now -4413.98% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$324.69 M
-$39.51 M-13.85%
September 1, 2024
Summary
- As of February 7, 2025, RNA TTM operating income is -$324.69 million, with the most recent change of -$39.51 million (-13.85%) on September 1, 2024.
- Over the past year, RNA TTM operating profit has dropped by -$102.61 million (-46.20%).
- RNA TTM operating profit is now -14835.14% below its all-time high of -$2.17 million, reached on March 31, 2019.
Performance
RNA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RNA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.7% | -67.4% | -46.2% |
| 3 y3 years | -432.1% | -235.2% | -238.9% |
| 5 y5 years | -2144.2% | -1785.0% | -1773.4% |
RNA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.6% | at low | -184.8% | at low | -175.0% | at low |
| 5 y | 5-year | -1259.3% | at low | -1522.8% | at low | -1773.4% | at low |
| alltime | all time | -2144.2% | at low | -4414.0% | at low | <-9999.0% | at low |
Avidity Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$98.13 M(+18.8%) | -$324.69 M(+13.9%) |
| Jun 2024 | - | -$82.63 M(+7.0%) | -$285.18 M(+11.8%) |
| Mar 2024 | - | -$77.19 M(+15.6%) | -$255.19 M(+8.3%) |
| Dec 2023 | -$235.60 M(+31.7%) | -$66.74 M(+13.8%) | -$235.60 M(+6.1%) |
| Sep 2023 | - | -$58.63 M(+11.4%) | -$222.08 M(+6.6%) |
| Jun 2023 | - | -$52.63 M(-8.6%) | -$208.38 M(+3.1%) |
| Mar 2023 | - | -$57.60 M(+8.2%) | -$202.05 M(+12.9%) |
| Dec 2022 | -$178.91 M(+51.6%) | -$53.23 M(+18.5%) | -$178.91 M(+8.9%) |
| Sep 2022 | - | -$44.93 M(-3.0%) | -$164.24 M(+10.5%) |
| Jun 2022 | - | -$46.30 M(+34.4%) | -$148.59 M(+15.5%) |
| Mar 2022 | - | -$34.46 M(-10.6%) | -$128.65 M(+9.0%) |
| Dec 2021 | -$118.05 M | -$38.55 M(+31.6%) | -$118.05 M(+23.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$29.28 M(+11.0%) | -$95.80 M(+22.8%) |
| Jun 2021 | - | -$26.37 M(+10.5%) | -$77.98 M(+25.8%) |
| Mar 2021 | - | -$23.86 M(+46.4%) | -$61.98 M(+40.0%) |
| Dec 2020 | -$44.28 M(+155.5%) | -$16.29 M(+42.1%) | -$44.28 M(+30.1%) |
| Sep 2020 | - | -$11.47 M(+10.6%) | -$34.03 M(+22.5%) |
| Jun 2020 | - | -$10.37 M(+68.6%) | -$27.77 M(+30.3%) |
| Mar 2020 | - | -$6.15 M(+1.7%) | -$21.31 M(+22.9%) |
| Dec 2019 | -$17.33 M(+65.1%) | -$6.05 M(+16.2%) | -$17.33 M(+53.6%) |
| Sep 2019 | - | -$5.21 M(+33.3%) | -$11.29 M(+85.6%) |
| Jun 2019 | - | -$3.90 M(+79.6%) | -$6.08 M(+179.6%) |
| Mar 2019 | - | -$2.17 M | -$2.17 M |
| Dec 2018 | -$10.50 M | - | - |
FAQ
- What is Avidity Biosciences annual operating income?
- What is the all time high annual operating profit for Avidity Biosciences?
- What is Avidity Biosciences annual operating profit year-on-year change?
- What is Avidity Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Avidity Biosciences?
- What is Avidity Biosciences quarterly operating profit year-on-year change?
- What is Avidity Biosciences TTM operating income?
- What is the all time high TTM operating profit for Avidity Biosciences?
- What is Avidity Biosciences TTM operating profit year-on-year change?
What is Avidity Biosciences annual operating income?
The current annual operating profit of RNA is -$235.60 M
What is the all time high annual operating profit for Avidity Biosciences?
Avidity Biosciences all-time high annual operating income is -$10.50 M
What is Avidity Biosciences annual operating profit year-on-year change?
Over the past year, RNA annual operating income has changed by -$56.69 M (-31.68%)
What is Avidity Biosciences quarterly operating income?
The current quarterly operating profit of RNA is -$98.13 M
What is the all time high quarterly operating profit for Avidity Biosciences?
Avidity Biosciences all-time high quarterly operating income is -$2.17 M
What is Avidity Biosciences quarterly operating profit year-on-year change?
Over the past year, RNA quarterly operating income has changed by -$39.51 M (-67.39%)
What is Avidity Biosciences TTM operating income?
The current TTM operating profit of RNA is -$324.69 M
What is the all time high TTM operating profit for Avidity Biosciences?
Avidity Biosciences all-time high TTM operating income is -$2.17 M
What is Avidity Biosciences TTM operating profit year-on-year change?
Over the past year, RNA TTM operating income has changed by -$102.61 M (-46.20%)